The effect of oral mummy drug on bone fracture

Phase 2

Completed

• Conditions: Tibia bone shaft fracture.; Fracture of shaft of tibia

• Registration Number: IRCT2013052013389N1
• Lead Sponsor: Vice chancellor for research, Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

1. The male gender 2. Fracture of tibia bone shaft 3. Initiation of intervention in less than 10 days from the time of fracture 4. Age between 18 and 50 5. Completing the consent form Exclusion criteria: 1. Orthopedic complication that prevents the continuation of the research process (in consultation with orthopedic surgeon and researcher) 2. The unpredictable complications leading to intolerance of medication or placebo such as idiosyncratic complications (in consultation with orthopedic surgeon and researcher) 3. Taking medications that affecting the bone repair 4. Surgery again 5. Pathological fracture 6. Underlying disease affecting the recovery process of fractures of the bone (immunodeficiency, tumor, osteoporosis, liver or renal failure) 7. Addiction 8. Severe infection of the bone or tissue around the location of the fracture or damage of the artery (according to the criteria of the Gustillo-Anderson 3C or 3B)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
nion time of tibia bone shaft fracture. Timepoint: Two, four, six, eight, ten and twelve weeks after the start of the intervention. Method of measurement: Swiss-ray digital radiology device.

Secondary Outcome Measures

Name	Time	Method
Side effects. Timepoint: Two, four, six, eight, ten and twelve weeks after the start of the intervention. Method of measurement: Questionnaire.